Search results
Showing 31 to 40 of 40 results for colonoscopy
Infliximab and adalimumab for the treatment of Crohn's disease (TA187)
Evidence-based recommendations on infliximab (Remicade) and adalimumab (Humira) for treating severe active Crohn's disease in adults.
This guideline covers managing colorectal (bowel) cancer in people aged 18 and over. It aims to improve quality of life and survival for adults with colorectal cancer through management of local disease and secondary tumours (metastatic disease).
continued for many years after people stopped taking aspirin. Regular colonoscopies, to spot cancers early if they develop, are...
Supporting the health and care system in improving productivity
Recovering core services and improving productivity is an immediate priority for the NHS. To help, we’ve put all our relevant guidance and recommendations supporting this work in one place.
Improving evidence-based management of irritable bowel syndrome across Somerset
for investigation with 5 patients having UC or CD but 3 having normal colonoscopies and one having a normal CT scan. Dietetic outcomes:...
assess diminutive polyps. Measures may include:- the length of time to do colonoscopies- the number of polyps sent for histopathology...
Around 100,000 fewer colonoscopies expected to take place each year following updated NICE guidance
Tens of thousands of people a year could be spared the need for a colonoscopy following new guidance from NICE.
Doctors have been advised to offer people with signs or symptoms of colorectal cancer a home test to reduce the waiting times for a colonoscopy, NICE has said in draft guidance.
Experts estimate that 450 to 500 people could be treated using FMT for multiple recurrences of C. diff infections each year.
Thousands of lives in England could be saved each year if the NHS follows updated guidance to help it diagnose cancer earlier. Here we outline what the guidance means for GPs.